The patients with NSCLC that were, however, wrongly labeled as negatives by CTC analysis could be correctly identified by EGFR analysis, and hence, the combined use of CTC biomarker and EGFR biomarker significantly improved the detection sensitivity. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.